Martin Pulé
Founder bij AUTOLUS THERAPEUTICS PLC
Vermogen: 4 M $ op 31-03-2024
Profiel
Martin Pulé is the founder of Autolus Therapeutics Plc, where he currently holds the title of Chief Scientific Officer & Senior Vice President.
Autolus Therapeutics Plc was founded in 2014.
Dr. Pulé is also the founder of Autolus Ltd.
Dr. Pulé's education history includes an undergraduate degree from University College Dublin.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
AUTOLUS THERAPEUTICS PLC
0.42% | 01-03-2023 | 698 741 ( 0.42% ) | 4 M $ | 31-03-2024 |
Actieve functies van Martin Pulé
| Bedrijven | Functie | Begin |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Founder | 01-09-2014 |
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Founder | - |
Opleiding van Martin Pulé
| University College Dublin | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Health Technology |
